๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Modulation of monoamine oxidase a activity in PC12 cells by steroids

โœ Scribed by Moussa B.H. Youdim

Book ID
115886646
Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
118 KB
Volume
192
Category
Article
ISSN
0014-2999

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Rasagiline, a novel monoamine oxidase-B
Rasagiline, a novel monoamine oxidase-B inhibitor with neuroprotective effects under ischemic conditions in PC12 cells
โœ Saleh Abu-Raya; Eran Blaugrund; Victoria Trembovler; Philip Lazarovici ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 122 KB ๐Ÿ‘ 1 views

Rasagiline (N-propargyl-1R-aminoindan) is a novel, potent, selective, and irreversible inhibitor of monoamine oxidase B (MAO-B), currently in Phase III trials for the treatment of Parkinson disease (PD). Rasagiline was shown to have neuroprotective properties in various in vitro and in vivo models i

Increased expression of monoamine oxidas
Increased expression of monoamine oxidase-B results in enhanced neurite degeneration in methamphetamine-treated PC12 cells
โœ Qize Wei; Octavian P. Jurma; Julie K. Andersen ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 374 KB

In vivo administration of methamphetamine (MA) produces selective damage to dopaminergic nerve terminals, which is hypothesized to be due to release of dopamine from synaptic vesicles within the terminals, allowing the generation of reactive oxygen species (ROS) via dopamine metabolism. Hydrogen per